Director, Value Outcomes Liaison (Central US)

Scorpion Therapeutics; United States; Remote; USD 140,000 - 190,000; Full time

Job summary

Scorpion Therapeutics is seeking a Director, Value Outcomes Liaison to engage US healthcare decision-makers and payers to support formulary access for ivonescimab, an innovative oncology therapy.

The role coordinates with HEOR and market access teams, providing clinical and health economic information, and shaping treatment pathways and guidelines to optimize patient access in NSCLC settings. Remote work with substantial travel is expected.

Qualifications

• MD, PharmD, or PhD in Health Services Research/Health Economics.
• 12+ years in healthcare, with at least 5+ in pharma, managed care, or consulting.
• Oncology experience, preferably in NSCLC.
• Strong analytical and communication skills.
• Proficiency in healthcare data and real-world evidence.

Responsibilities

• Building relationships with PBDMs.
• Collaborating with HEOR and market access teams.
• Providing clinical and health economic information.
• Ensuring inclusion of ivonescimab in treatment pathways and guidelines.

Skills

Analytical skills

Communication skills

Education

MD

PharmD

PhD in Health Services Research/Health Economics

Job description

Director, Value Outcomes Liaison, responsible for engaging US healthcare decision-makers and payers to support formulary access for ivonescimab, a novel immunotherapy in oncology.

Responsibilities

• building relationships with PBDMs
• collaborating with HEOR and market access teams
• providing clinical and health economic information
• ensuring inclusion of ivonescimab in treatment pathways and guidelines

Requirements

MD, PharmD, or PhD in Health Services Research/Health Economics; 12+ years in healthcare, with at least 5+ in pharma, managed care, or consulting; oncology experience, preferably in NSCLC; strong analytical and communication skills; proficiency in healthcare data and real-world evidence; ability to influence stakeholders.

High Value

Oncology (NSCLC), immunotherapy, market access, formulary strategy, US healthcare system, health economic evidence, cross-functional collaboration.

Work Setup

remote with up to 75% travel.